BioCentury | May 16, 2016
Financial News

Asana Medical completes venture financing

Asana Medical Inc. , Miami Lakes, Fla. Business: Autoimmune, Gastrointestinal Date completed: 2016-05-10 Type: Venture financing Raised: $1.2 million Note: The financing comprises convertible promissory notes. WIR Staff autoimmune Gastrointestinal...
BioCentury | Feb 15, 2016
Financial News

Regentis Biomaterials completes venture financing

Regentis Biomaterials Ltd. , Or Akiva, Israel Business: Musculoskeletal Date completed: 2016-02-08 Type: Venture financing Raised: $15 million Investors: Haisco; Medica Venture Partners; SCP Vitalife Partners; Generali Investment; Technion Investment Opportunities Fund WIR Staff Musculoskeletal...
BioCentury | Jul 27, 2015
Company News

University of Pittsburgh, Asana Medical deal

...not respond to inquiries about financial terms and ECMH. University of Pittsburgh , Pittsburgh, Pa. Asana Medical...
BioCentury | Sep 30, 2013
Clinical News

GelrinC implant: Phase I/II data

A single-arm, open-label, European and Israeli Phase I/II trial in 23 patients with knee cartilage damage showed that Regentis' GelrinC implant led to a 60% improvement in KOOS scores, excluding the sports subscale, from baseline...
BioCentury | May 21, 2012
Financial News

Regentis Biomaterials completes venture financing

Regentis Biomaterials Ltd. , Or-Akiva, Israel Business: Musculoskeletal Date completed: 5/14/12 Type: Venture financing Raised: $10 million Investors: Royal DSM N.V. ; Crossroad Fund; Medica Venture Partners; SCP Vitalife Partners; Technion Investment Opportunities Fund WIR Staff...
Items per page:
1 - 5 of 5
BioCentury | May 16, 2016
Financial News

Asana Medical completes venture financing

Asana Medical Inc. , Miami Lakes, Fla. Business: Autoimmune, Gastrointestinal Date completed: 2016-05-10 Type: Venture financing Raised: $1.2 million Note: The financing comprises convertible promissory notes. WIR Staff autoimmune Gastrointestinal...
BioCentury | Feb 15, 2016
Financial News

Regentis Biomaterials completes venture financing

Regentis Biomaterials Ltd. , Or Akiva, Israel Business: Musculoskeletal Date completed: 2016-02-08 Type: Venture financing Raised: $15 million Investors: Haisco; Medica Venture Partners; SCP Vitalife Partners; Generali Investment; Technion Investment Opportunities Fund WIR Staff Musculoskeletal...
BioCentury | Jul 27, 2015
Company News

University of Pittsburgh, Asana Medical deal

...not respond to inquiries about financial terms and ECMH. University of Pittsburgh , Pittsburgh, Pa. Asana Medical...
BioCentury | Sep 30, 2013
Clinical News

GelrinC implant: Phase I/II data

A single-arm, open-label, European and Israeli Phase I/II trial in 23 patients with knee cartilage damage showed that Regentis' GelrinC implant led to a 60% improvement in KOOS scores, excluding the sports subscale, from baseline...
BioCentury | May 21, 2012
Financial News

Regentis Biomaterials completes venture financing

Regentis Biomaterials Ltd. , Or-Akiva, Israel Business: Musculoskeletal Date completed: 5/14/12 Type: Venture financing Raised: $10 million Investors: Royal DSM N.V. ; Crossroad Fund; Medica Venture Partners; SCP Vitalife Partners; Technion Investment Opportunities Fund WIR Staff...
Items per page:
1 - 5 of 5